Exploring Clinical Trial Experiences of Patients With Migraine
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorPower Life Sciences Inc.
About this trial
Clinical study participation has historically been heavily biased toward specific demographics.
This study will invite several participants to gather a wide range of information on clinical trial experiences for migraine patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of migraine.
People with migraine who are invited to take part in medical research will benefit from the analysis of the data.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient is a minimum of 18 years of age
Patient has been diagnosed with a type of migraine
Patient plans to participate in an interventional clinical trial for the condition of migraine
Patient has access to a home internet connection in order to provide regular updates through the course of the study
Disqualifiers
Patient has an ECOG score of 4 or higher
Patient is not able to provide consistent digital updates as per study requirements
Patient does not complete or agree to terms outlined in the Informed Consent Form
Trial population
Patients with migraine who are actively considering enrolling in an interventional clinical trial for said condition, but have not yet completed enrollment and randomization phases in said clinical trial.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of patients who decide to enroll in a migraine clinical trial
Time frame
3 months2
Rate of patients who remain in migraine clinical trial to trial completion
Time frame
12 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: